InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Boudreau Helen M, Director. Officer active across 3 companies, notably Premier, Inc.. Aggregated, 10 disclosures have been logged. Split: 0 buy · 3 sells. Total volume traded: €213k. Activity tracked since 6 December 2021. The latest transaction was disclosed on 6 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Boudreau Helen M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
3,562 shares@ US$2.380.0092% mcap100.0% of flowCommon StockSEC:0001193125-26-300913:0
18,668 shares@ US$28.2568.2% of flowClass A Common StockSEC:0001193125-25-298830:0
2,000 shares@ US$22.8818.9% of flowClass A Common StockSEC:0000950170-25-080414:0
2,500 shares@ US$21.4230.1% of flowClass A Common StockSEC:0000950170-25-002730:0
7,101 shares0Class A Common StockSEC:0000950170-24-134910:0
150,647 shares0Common StockSEC:0001415889-24-015765:0
6,629 shares@ US$19.8569.9% of flowClass A Common StockSEC:0000950170-24-061022:0
7,333 shares0Class A Common StockSEC:0001209191-23-057475:0
4,636 shares0Class A Common StockSEC:0001209191-22-060180:0
4,098 shares0Class A Common StockSEC:0001209191-21-068239:0
10 of 10 declarations
About Boudreau Helen M
Boudreau Helen M is Administrateur at Premier, Inc., Rallybio Corp and Cara Therapeutics, Inc. She has 10 filings in total; across the 10 sampled filings, the sell volume is EUR 670798, with transactions dated from 2021-12-07 to 2026-07-10 and the transaction nature listed as Attribution.
